虽然这项研究不会直接导致用于治疗感染或疾病的新疗法，但它将使研究人员更好地了解免疫系统遵循的规则。研究人员如今更清楚地知道，在开发治疗方案时，应该拉动哪些杠杆来做出更有效的选择，以防止T细胞遵循功能衰竭的路线，并推动它们继续进行良好的斗争。（ 生物谷 Bioon.com） ...

Expression of tissue factor (TF) in penile squamous cell carcinoma (PSCC) and enrichment in HPV-negative cases. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium.

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...

The researchers showed that removing Asxl1 prevented T-cell exhaustion, enabling long-term immune responses. "We found Asxl1 ...

Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer immunotherapy.

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...